dc.contributor.author | Vojtěchová, Zuzana | |
dc.contributor.author | Milt, Petr | |
dc.contributor.author | Saláková, Martina | |
dc.contributor.author | Šmahelová, Jana | |
dc.contributor.author | Lohynská, Radka | |
dc.contributor.author | Lacek, Michal | |
dc.contributor.author | Čoček, Aleš | |
dc.contributor.author | Krátká, Zuzana | |
dc.contributor.author | Tachezy, Ruth | |
dc.date.accessioned | 2024-11-25T13:40:48Z | |
dc.date.available | 2024-11-25T13:40:48Z | |
dc.date.issued | 2024 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/2710 | |
dc.description.abstract | The clinical utility of liquid biopsies as diagnostic, predictive and prognostic biomarkers has been shown for several cancers. Our study focuses on analyzing the dynamics of HPV cell-free DNA (cfDNA) levels during the surveillance of patients with oropharyngeal tumors to improve the management of patients. We present preliminary data on the evaluation of plasma collection methods, and their efficiency in subsequent analyses of the dynamics of HPV cfDNA level. | en |
dc.language.iso | en | |
dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.title | The biomolecular markers for the personalized prediction of the treatment effect in patients with head and neck cander: pilot study | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
dc.date.updated | 2024-11-25T13:40:48Z | |
dc.subject.keyword | cell-free DNA | en |
dc.subject.keyword | head and neck cancer | en |
dc.subject.keyword | plasma | en |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
dc.date.embargoStartDate | 2024-11-25 | |
dc.type.obd | 110 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.obd | 655052 | |
dc.subject.rivPrimary | 30000::30200::30204 | |
dcterms.isPartOf.name | 26th Annual Conference of the European Society for Clinical Virology | |
dcterms.isPartOf.journalYear | 2024 | |
uk.faculty.primaryId | 115 | |
uk.faculty.primaryName | Přírodovědecká fakulta | cs |
uk.faculty.primaryName | Faculty of Science | en |
uk.department.primaryId | 1034 | |
uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
uk.department.primaryName | Department of Genetics and Microbiology | en |
uk.event.name | ESCV 2024/26th Annual Conference of the European Society for Clinical Virology | |
dc.description.pageRange | 232-232 | |
dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v elektronické podobě | cs |
dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in e-form | en |
dc.type.obdHierarchyCode | 110::130::136 | en |
uk.displayTitle | The biomolecular markers for the personalized prediction of the treatment effect in patients with head and neck cander: pilot study | en |